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Abstract





Few studies have been conducted on the effect of in vitro selenium
(Se) supplementation on cellular immunity. In the present study, the
effects of in vitro incubation with sodium selenite on natural killer
(NK)-mediated cytotoxicity and phagocyte chemiluminescence (CL) were
NK-mediated cytotoxicity and phagocyte CL were observed toexamined.
be affected by added selenite. These changes generally included
augmentation and suppression of both neutrophil CL and NK-mediated
All dosages of selenite used were shown to be capable ofcytotoxicity.
However, 1.0 /xg/ml selenite wascausing augmentation of neutrophil CL.
also observed to occasionally cause depression of neutrophil CL. When
Se supplementation enhanced NK cytotoxicity, the effect was always
observed at 0.1 /xg/ml selenite dosage. Higher dosages of selenite
induced both enhancement and depression of activity. The existence of
a narrow dosage-window is evident.
The activity of the selenoenzyme glutathione peroxidase (GSH-Px)
was also determined in NK cells and phagocytes following selenite
supplementation. Dose-dependent augmentation of phagocytic activity by
selenite supplementation was accompanied by a corresponding increase in
The effect of Se treatment on non-adherentphagocyte GSH-Px activity.
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Introduction
Selenium (Se) is an essential trace element which influences the
immune response and host defense mechanisms (1-7). At nutritional
levels, Se possesses a broad spectrum of anticarcinogenic (8-12) and
antimutagenic activity (13-17). Epidemiological data suggest that
adequate dietary levels of Se are associated with a decreased risk of
developing cancer while deficiency may be related to an increased
cancer risk (18-21). The immune system mediates an array of cytotoxic
mechanisms intimately involved in the surveillance against neoplastic
Several studies suggest that adequate levels of nutritionaldisease.
Se are required for the optimal functioning of various components of
the immune system, such as the humoral immune response (22,23), natural
killer (NK) cell-mediated cytotoxicity (3,5,6,7) as well as
polymorphonuclear leukocyte (PMN) function (1,2,24). Se deficiency in
cows (24) and goats (1,2) is associated with impaired phagocytic
function. NK cytotoxicity has been shown to be enhanced by dietary Se
supplementation in rats and humans (3,5,7). The role of Se in the
microbicidal activity of phagocytes is perhaps the best studied. It
has been widely suggested that glutathione peroxidase (GSH-Px), a
selenium-containing enzyme, is central in this regard. Se deficiency
leads to decreased activity of phagocyte GSH-Px (1,25). This enzyme
appears to be involved in protecting phagocytes against deleterious
effects of hydrogen peroxide (H2O2) generated in association with 
superoxide (0_2), singlet oxygen (^C^) and hydroxyl radicals (OH*) (26- 
These toxic reactive oxygen species mediate the microbicidal27).
activity associated with phagocytosis (28). The involvement of GSH-Px
1
2
on Se-modified NK activity has also been suggested but not evaluated
(3).
Few of the published studies have been conducted in vitro, where
valuable information regarding the cellular mechanisms of Se-modified
immunosurveillance might be obtained. Dimitrov et al. (3) failed to
demonstrate enhancement of NK activity with the in vitro addition of
Se, though enhancement was demonstrated in corresponding in vivo
Watson et al. (29) could only demonstrate depression of NKstudies.
activity at relatively high levels of Se. Virtually all studies of the
effect of Se on phagocytic function involve dietary experiments where
Se was given orally and phagocytic function and GSH-Px activity were
subsequently evaluated in the peripheral blood. The present study
examined the effect of in vitro Se supplementation on NK cytotoxicity,
neutrophil chemiluminescence (CL) and the intracellular GSH-Px activity
of neutrophils and NK cells.
Materials and Methods
Normal Volunteers. This study was carried out using peripheral
blood obtained from seven healthy volunteers (24 to 50 years old) of
both sexes (four males and three female). Only one had taken selenium
supplements. Informed consent was obtained from each volunteer before
the beginning of the study. The study was approved by the
Institutional Review Board for Human Studies. No volunteer contributed
more that 50 ml of blood during any monthly period.
Lymphocyte Preparation. Venous blood samples were collected by
appropriate venipuncture into vacutainer tubes containing heparin
(Becton-Dickinson, Rutherford, NJ). Mononuclear cell were prepared
from heparinized blood samples by Ficol-Hypaque (Pharmacia Fine
Chemicals, Piscataway, NJ) density gradient centrifugation. The cells
were washed twice in Hanks Balanced Salt Solution (HESS) and suspended
in tissue culture medium consisting of RPMI-1640 with 10% fetal calf
serum (FCS), 1000 units/ml penicillin and 375 units/ml streptomycin
(designated as TC medium henceforth). Phagocytes were removed from the
lymphocytes by incubation for 20 minutes at 37°C in an atmosphere of 5%
CO2 in plastic petri dishes (Becton Dickinson Labware, Oxnard, CA).
The non-adherent lymphocytes were collected, washed and contaminating
erythrocytes lysed with potassium bicarbonate-ammonium chloride buffer
(ACK lysing buffer). The resulting erythrocyte-free cells were
resuspended to the desired concentration in TC medium. Viability of
these cells was greater than 95% by trypan blue exclusion.
Neutrophil Preparation. Polymorphonuclear leukocytes (PMNs) were
isolated and purified from heparinized whole blood by density gradient
centrifugation using Neutrophil Isolation Medium (United Technologies
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Packard, Downers Grove, IL) followed by lysis of contaminating
erythrocytes with ACK-lysing buffer. Cell suspensions thus prepared
contained greater than 98% PMN and viability assessed by trypan blue
After purification, the PMNs wereexclusion was in excess of 99%.
suspended in Medium 199 without indicator supplemented with 20% heat
inactivated PCS, 550 ng/ml heparin, 1000 units/ml penicillin and 375
units/ml streptomycin.
Non-adherent cells were suspended inNatural Killer Cell Activity.
TC medium and their concentrations were adjusted to ultimately
The target cells (K-obtain 100:1 and 50:1 effector:target ratios.
562), a human erythroleukemia cell line, were grown as stationary
suspension cultures in TC medium supplemented with 1 mM sodium
These cells were labeled with 100-200 /iCi/ml of chromium-51pyruvate.
as sodium chromate (New England Nuclear Research Products, Boston, MA) 
per 2-5 x 10^ cells/ml at 37°C in 5% CO2 for 2 hours. They were washed 
four times in TC medium and resuspended to 5 x 10^ cells/ml. Viability 
was determined by trypan blue exclusion and found to be greater than 
95%. Labeled K-562 cells were added in 100 /xl aliquots to the
appropriate wells of 96-well flat-bottom microtiter plates (Corning
Glass Works, Corning, NY) containing 100 /il of varying concentrations
100 /xl of sodium selenite solutions were then addedof effector cells.
to appropriate wells at concentrations adjusted to obtain final
All tests wereconcentrations of 0.1, 0.5 and 1.0 /zg/ml, respectively.
performed in triplicate. After centrifugation at 1000 rpm for 2 
minutes, the plates were incubated at 37°C in 5% CO2 for 4 hours. 
After incubation, supernatants were harvested using a Skatron
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Supernatant Collection System (Skatron Inc., Sterling, VA) and
radioactivity counted in a TM Analytic Gamma Trac 1193 gamma counter
(TM Analytic, Elk Grove Village, IL). Percent cytotoxicity was
calculated as follows:
Experimental Release 
Maximum Release X 100% cytotoxicity =
where maximum release represents target cells that were lysed with 10%
sodium dodecyl sulfate (SDS). The 50:1 ratio was determined to give
the most consistent results and subsequently was used throughout this
s tudy.
Chemiluminescence (CL) Determination of Phagocytosis. Isolated
PMNs were divided into four aliquots. The control aliquot was pre-
incubated without sodium selenite in siliconized glass tubes for 30
minutes at 37°C in 5% CO2. The experimental aliquots were handled
similarly except sodium selenite dissolved in HESS was added before
pre-incubation to obtain final concentrations of 0.1, 0.5 and
1.0 /ig/ml, respectively. The chemiluminescent response of the
pretreated cells was used as a measure of reactive oxygen species
production and assayed at 37°C in a luminometer (Picolite model 6500,
Packard Instrument Co., Downers Grove, IL) interfaced with a PC-
compatible computer for data acquisition and processing. All
luminometry experiments were performed in triplicate. Briefly,
pretreated PMNs were added to 55 x 12 mm plastic luminometry tubes (Los
Alamos Diagnostics, Los Alamos, NM) such that each tube contained 
5 x 10^ cells in a total volume of 50 /xl. The tubes were then
transferred to the luminometer. The assay was initiated by the
addition of 150 /xl of an opsonized zymosan A suspension containing
6
TMluminol (ZAP , Los Alamos Diagnostics). The photon emission from each
sample was counted every 3 minutes over the course of 30 minutes.
Following the assay, the area under each curve representing light
emission versus time was calculated and reported as integrated photon
emission (30).
Glutathione Peroxidase Determination. Isolated neutrophils were
prepared and treated with sodium selenite as previously described.
Isolated lymphocytes were divided into four aliquots and treated with
sodium selenite as described for phagocytes. After incubation, the
cells were washed twice with potassium phosphate buffer (31) and 
resuspended in 2 ml to a concentration between 5 x 10^ and 1 x 10^
cells/ml. All samples were then sonicated (Branson Sonifier Cell
Disrupter 200, Danbury, CT) in the cold with four 10 second pulses,
then centrifuged at 10,000 rpm for 20 minutes at 4°C in a Sorvall RC-5C
Refrigerated Centrifuge (Sorvall Instruments, Wilmington, DL). The
supernatant was removed for GSH-Px and protein determinations.
GSH-Px was measured using the spectrophotometric method developed
by Paglia and Valentine (32) as modified by Levander et al. (31). The
absorbance was read in a Spectronic 1001 (Baush and Lomb, Rochester,
NY) before the reaction was initiated with t-butyl hydroperoxide and at
subsequent 1 minute intervals. Absorbance change from 0 to 5 minutes
was used to calculate enzyme activity. One enzyme unit is equal to
1 /imole NADPH oxidized per minute and is expressed as /xmoles NADPH
oxidized/min/mg/ml protein.
Protein Determination. Protein concentrations of cell sonicates
were determined using a spectrophotometric method (33). Briefly, cell
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sonicate was pipetted into a quartz cuvette and its absorbance was read
at 280 run and 260 ran in a Spectronic 1001. Protein concentration was
then calculated as follows:
[Protein] = A28o/A260 X F X 1/d,
where A280 is absorbance at 280 ran, A26O is absorbance at 260 ran, F is
a conversion factor and d is the 1 cm pathlength.
Statistical Analysis. Data were evaluated using either one-way
analysis of variance and Tukey's HSD (honestly significant difference)
test for multiple comparisons or Student's two-tailed t-test. All
statistical procedures were performed with Statgraphics software
P < 0.05 was used for theversion 2.1 (STSC, Inc., Rockvill, MD).
significance level in Tukey's HSD procedure.
Results
Effect of Selenite on Neutrophil CL. The in vitro addition of
sodium selenite to normal human phagocytes caused alterations of
phagocytic activity as measured by CL. Table 1 shows the results with
samples obtained from seven subjects at various time intervals. All
dosages of selenite used induced significant enhancement of CL in
samples 2 and 3. 0.1 and 0.5 /xg/ml selenite caused significant
enhancement of CL in sample 1. However 1.0 /ig/ml selenite induced a
suppression of activity. Samples 7,9 and 10 showed no changes in CL
with the addition of 0.1 and 0.5 /ig/ml selenite but enhancement with
the addition of 1.0 /xg/ml selenite. Significant suppression of CL upon
the addition of 1.0 /jg/ml selenite was also observed in sample 4 but
the addition of the two lower dosages of selenite used did not induce
any change. Samples 5,6,8 and 11 exhibited no significant change in CL
upon the addition of all selenite dosages used.
Figures 1-5 illustrate the five patterns of CL exhibited in
response to added selenite. The five patterns are characterized by:
enhancement of CL with all three dosages of sodium selenite (Figure 1),
enhancement of CL with 0.1 and 0.5 Mg/ml selenite but depression with
1.0 /xg/ml selenite (Figure 2), no effect on CL with the addition of 0.1
and 0.5 jig/ml selenite but enhancement with 1.0 fig/val selenite (Figure
3), no effect with 0.1 and 0.5 ng/ral selenite and depression with 1.0
/ig/ml selenite (Figure 4) and finally, no significant effect with all
three dosages of selenite (Figure 5).
Effect of Selenite on Natural Killer Activity. The effect of
sodium selenite on NK cytotoxicity in vitro is shown in Table 2.
Samples were obtained from five subjects at various time intervals.
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Seven of the twelve samples exhibited significant enhancement upon
Four of the samples exhibitedaddition of 0.1 /xg/ml selenite.
enhancement of cytotoxicity upon addition of 0.5 /xg/ml selenite, while
three samples exhibited depression of activity at this dosage.
Addition of 1.0 /xg/ml selenite induced enhancement of activity in two
samples and depression in three samples. All three concentrations of
selenite used were found to be non-toxic to K-562 tumor target cells.
Figure 6 illustrates six patterns of NK cytotoxic responses to
selenite. Enhancement of activity with all three dosages of selenite
characterized the first response. Enhancement of activity with 0.1 and
0.5 /xg/ml of selenite but no significant changes with 1.0 /zg/ml of
selenite characterized the second response. The third response
appeared as enhancement with 0.1 /ig/ml of selenite and no changes with
0.5 and 1.0 /xg/ml of selenite. The fourth response was characterized
by enhancement of activity with 0.1 /ug/ml of selenite and suppression
with 0.5 and 1.0 /ig/ml. The fifth response appeared as no changes in
activity with 0.1 /ig/ml of selenite but suppression with 0.5 and 1.0
/ig/ml. No significant changes in activity with the addition of all
dosages of selenite characterized the sixth response.
Effect of Selenite on GSH-Px Activity. CL and GSH-Px activity were
simultaneously evaluated and the results are shown in Table 3.
Selenite supplementation in samples 1-4 induced similar changes in both
neutrophil CL and GSH-Px activity. When Se enhanced CL, a concomitant
increase in GSH-Px was observed. Reciprocally, when Se had no effect
on CL, as in sample 5, no alteration in GSH-Px could be discerned.
GSH-Px activity was evaluated in samples of non-adherent cells used
10
The effect of Se supplementation onin the NK cytotoxicity assays.
GSH-Px activity did not correlate with NK activity. (Data not shown).
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Table 1
EFFECT OF SELENITE ON CHEMILUMINESCENCE
Subject Sample Selenite Dosage
# #
Control 0.1 /xg/ml 0.5 /zg/ml 1.0 /zg/ml
Integrated Photon Emission x 10^ ± SEM
4.63 ± 0.38* 4.17 ± 0.17* 2.78 ± 0.04t1 1 3.47 ± 0.24
1.71 ± 0.03* 1.56 ± 0.08* 1.61 ± 0.03*2 1.20 ± 0.14
3.40 ± 0.16* 3.73 ± 0.17* 3.24 ± 0.04*3 2.74 ± 0.19
2.22 ± 0.10t2 4 4.82 ± 0.80 4.55 ± 0.41 5.49 ± 0.30
5 3.33 ± 0.25 3.14 ± 0.44 3.07 ± 0.10 3.26 ± 0.02
6 1.37 ± 0.16 1.57 ± 0.03 1.53 ± 0.08 1.51 ± 0.02
7.43 ± 0.06*3 6.63 ± 0.127 6.84 ± 0.15 6.98 ± 0.09
4 8 8.17 ± 0.01 8.69 ± 0.02 8.58 ± 0.02 9.00 ± 0.04
58.6 ± 0.05*5 9 53.0 ± 0.04 54.8 ± 0.02 54.1 ± 0.01
38.9 ± 0.03*6 10 35.8 ± 0.01 33.8 ± 0.03 34.2 ± 0.03
7 11 73.3 ± 0.04 79.0 ± 0.03 76.2 ± 0.04 78.0 ± 0.02
» » m 0 iSignificant increases (p<0.05) in activity; T significant suppression 
(p<0.05) in activity; determined by Tukey's HSD test.
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Table 2
EFFECT OF SELENITE ON NK CYTOTOXICITY
Subject Sample Selenite Dosage
# #
Control 0.1 /ig/ml 0.5 ng/ml 1.0 /ig/ml
% Cytotoxicity ± SEMa
81.6 ± 1.45* 74.1 ± 6.10*1 1 69.8 ± 2.63 71.3 ± 1.00
2 73.5 ± 2.45 82.2 ± 2.70 74.8 ± 3.30 74.0 ± 4.50
56.6 ± 2.85*57.3 ± 2.90* 59.1 ± 1.70*2 3 44.8 ± 1.35
4 45.7 ± 1.00 47.2 ± 0.01 39.0 ± 7.10 39.6 ± 0.40
54.2 ± 2.36*5 49.8 ± 1.55 46.3 ± 0.86 49.3 ± 1.66
67.5 ± 2.00* 61.0 ± 4.25*3 6 53.2 ± 1.56 58.5 ± 6.50
69.0 ± 0.32* 63.9 ± 0.20t 64.0 ± O.iot7 64.7 ± 0.05
50.4 ± 1.15*52.1 ± 1.15* 49.2 ± 2.75*4 8 37.2 ± 1.30
43.4 ± 4.25t 39.4 ± 3.00t9 52.4 ± 0.80 45.6 ± 0.50
10 48.1 ± 1.72 50.9 ± 1.65 47.9 ± 0.47 52.5 ± 0.21
54.9 ± 1.95*38.6 ± 1.95t 37.4 ± l.iot5 11 43.5 ± 0.45
12 35.3 ± 2.75 41.2 ± 0.35 38.5 ± 1.75 33.7 ± 0.65
a50:l cell ratio used.• • • •Significant increase (p<0.5) in activity as determined by 
Tukey's HSD test.


















1 0 1.20 ± 0.14 
1.71 ± 0.03 
1.56 ± 0.08 
1.61 ± 0.03
1.91 ± 0.02 
2.49 ± 0.08 






2 0 2.74 ± 0.19 
3.40 ± 0.16 
3.73 ± 0.17 
3.24 ± 0.04
1.44 ± 0.01 
1.47 ± 0.01 
1.54 ± 0.02 
1.49 ± 0.03
* *
0.1 * * * *
0.5 **
1.0 * *
3 0 3.47 ± 0.24 
4.63 ± 0.38 




0.5 2.21 ± 0.11*
1.0 * ND
4 0 4.82 ± 0.80 
4.55 ± 0.41 




0.5 4.41 ± 0.04*
1.0 * ND
5 0 3.33 ± 0.25 
3.14 ± 0.44 
3.07 ± 0.10 
3.26 ± 0.02
1.43 ± 0.01
1.44 ± 0.04 





Chemiluminescence expressed as mean integrated photon emission ± SEM 
(x 107).
D^mole NADPH oxidized/min/mg/ml protein ± SEM. 
tDetermined by Student's two-tailed t-test.
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Figure 1. The effect of selenite on chemiluminescence exhibiting
significant (p<0.05) enhancement of chemiluminescence with all dosages
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Figure 2. The effect of selenite on chemiluminescence exhibiting
significant (p<0.05) enhancement of chemiluminescence with 0.1 and 0.5
/ig/ml selenite and significant (p<0.05) depression with 1.0 /xg/ml
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Figure 3. The effect of selenite on chemiluminescence exhibiting
no significant changes with the addition of 0.1 and 0.5 jug/ml selenite
but significant enhancement with 1.0 /ig/ml selenite. Chemiluminescence
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Figure 4. The effect of selenite on chemiluminescence exhibiting
significant (p<0.05) depression of chemiluminescence with 1.0 /xg/ml
selenite. 0.1 and 0.5 /xg/ml selenite had no affect on
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Figure 5. The effect of selenite on chemiluminescence exhibiting
no significant changes with the addition of all dosages of selenite























0.0 1 l I 1 1 1
0.0 0.2 0.4 0.6 0.8 1.0
Selenite Dosage (//g/ml) ho
u>
24
Figure 6. The effect of selenite on NK cytotoxicity demonstrating
six different responses to in vitro selenite supplementation.
** represents significant (p<0.05) enhancement of activity.
f represents significant (p<0.05) suppression of activity.
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Discussion
This study demonstrates that the activities of human NK cells and
neutrophils were affected by in vitro incubation with sodium selenite.
These effects included augmentation and suppression of neutrophil CL
All dosages of selenite used were shownand NK-mediated cytotoxicity.
In some samplesto be capable of inducing augmentation of CL activity.
of phagocytic cells, the addition of 1.0 /ig/ml selenite caused a
depression of phagocytic activity. When Se supplementation enhanced NK
cytotoxicity, the effect was always observed at 0.1 /xg/ml selenite. At
the two higher dosages used, selenite induced both enhancement and
depression of activity. These results are in agreement with those
obtained from dietary Se supplementation of humans and animals. Aziz
et al. (1) and Gyang et al (24) demonstrated a dose-dependent increase
in PMN function in goats and cows receiving Se supplementation.
Talcott et al. (7) and Koller et al. (5) both observed a dose-dependent
enhancement of NK activity in rats after in vivo supplementation with
Dimitrov et al. (3) demonstrated a similar dose-dependentSe.
enhancement of NK activity in humans receiving a selenium supplement.
The findings of this study contradict those of Watson (29) and
Dimitrov (3). Neither investigator observed significant augmentation
of NK activity with in vitro supplementation of sodium selenite. These
authors did, however, observe significant depression of NK activity
when cells were incubated in vitro at selenite dosages of 1.0 /xg/ml or
greater. The differences between these reports and the present study
may be due to the fact that Dimitrov's group employed an 18 hour
preincubation of mononuclear cells in selenite prior to performing the
NK cytotoxicity assay while Watson preincubated cells for 48 hours
26
27
These long preincubations are in contrast to theprior to the assay.
procedure employed in this study wherein selenite was added directly to
the effector-target wells at the start of the actual NK cytotoxicity
Moreover, Nabel (34) reported that NK cells undergo a loss ofassay.
activity in as few as 6 hours when maintained in vitro at 37°C.
During the course of this investigation, there were samples which
demonstrated no significant augmentation of phagocytic or NK activity
as a function of Se supplementation. This perhaps reflects the
presence of ideal intracellular Se levels before treatment. Depression
of NK cytotoxicity and neutrophil-mediated CL upon Se supplementation
may indicate Se toxicity resulting from an increase in intracellular Se
Though intracellularlevels over ideal intracellular concentrations.
and plasma Se levels were not evaluated in this study, this view finds
support in the literature. Severe systemic Se toxicity has been
reported in the People's Republic of China in individuals whose whole
Severe Se toxicity was alsoblood Se levels averaged 3200 ng/ml (35).
reported in a New York woman taking Se supplements containing 27.3 mg
Her serum Se level was reported as 528 ng/ml,per tablet (36).
approximately four times the normal levels for the U.S. population.
The proposed adequate and safe daily dosage of Se is 50-200 /zg per day.
Serum Se levels much lower than those reported in individuals with
Dimitrovsystemic Se toxicity have been found to cause immunotoxicity.
(3) demonstrated increases in plasma Se levels from 0.11 /zg/ml to 0.12
/xg/ml were associated with increases in NK cytotoxicity. However,
increases in plasma Se levels beyond 0.12 ng/ml began to depress
Thereforeactivity. A narrow dosage-window appears to be evident.
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caution should be exercised in recommending Se supplementation. Tests
evaluating immune function or intracellular Se levels may be valuable
in deciding whether supplementation is warranted.
Previous investigators have demonstrated that Se deficient animals
exhibited a marked reduction in phagocytic intracellular killing with a
corresponding reduction in the activity of the selenoenzyme GSH-Px
In animals, the level of phagocyte GSH-Px activity appears(1,2,4,25).
to be directly dependent upon the Se concentration in the phagocyte's
The present study of human neutrophils is inenvironment (1).
agreement with the results obtained in animals. Dose-dependent
augmentation of CL by in vitro selenite supplementation was accompanied
Conversely,by a corresponding increase in phagocyte GSH-Px activity.
dose-related changes in GSH-Px levels were observed in neutrophilsno
which exhibited no change in CL as a function of selenite treatment.
The view that selenium-enhanced phagocytic activity is mediated via
GSH-Px (1) is sustained by these data.
In addition to the anti-oxidant role of GSH-Px, this enzyme has
been demonstrated to be closely coupled to arachidonic acid
Since NK activity is dependent upon arachidonicmetabolism (37-40).
acid metabolism (41), a correlation between selenium-enhanced NK
Addition ofactivity and intracellular GSH-Px levels was sought.
selenite to non-adherent cells had effects on GSH-Px activity which did
not correlate with previously determined NK activity. This suggests
that GSH-Px may not be involved in selenite-induced enhancement of NK
cytotoxicity. Further investigation is therefore warranted.
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